Signum Biosciences' Series A Round

Signum Biosciences raised a round of funding on January 22, 2007.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Series A Round: